Peer Review reports
From: The PDGFRβ/ERK1/2 pathway regulates CDCP1 expression in triple-negative breast cancer
| Original Submission | ||
|---|---|---|
| 4 Oct 2017 | Submitted | Original manuscript |
| 13 Oct 2017 | Author responded | Author comments - Luca Forte |
| Resubmission - Version 2 | ||
| 13 Oct 2017 | Submitted | Manuscript version 2 |
| 26 Oct 2017 | Author responded | Author comments - Luca Forte |
| Resubmission - Version 3 | ||
| 26 Oct 2017 | Submitted | Manuscript version 3 |
| 20 Nov 2017 | Reviewed | Reviewer Report - Khalid Alfarouk |
| 28 Nov 2017 | Reviewed | Reviewer Report - Durga Attili |
| 19 Jan 2018 | Author responded | Author comments - Luca Forte |
| Resubmission - Version 4 | ||
| 19 Jan 2018 | Submitted | Manuscript version 4 |
| 20 Apr 2018 | Author responded | Author comments - Luca Forte |
| Resubmission - Version 5 | ||
| 20 Apr 2018 | Submitted | Manuscript version 5 |
| 27 Apr 2018 | Author responded | Author comments - Luca Forte |
| Resubmission - Version 6 | ||
| 27 Apr 2018 | Submitted | Manuscript version 6 |
| Publishing | ||
| 11 May 2018 | Editorially accepted | |
| 23 May 2018 | Article published | 10.1186/s12885-018-4500-9 |
You can find further information about peer review here.